<h4>The Co-Investing Atrium will take place on <strong>May 29th, 2025, </strong>bringing together a curated circle of up to 15 international investors with interest in consumer goods, impact investing, and sustainable innovation to:</h4> <p>&nbsp;</p> <ul> <li>Engage in networking and one-to-one meetings with each other</li> <li>Share insights on emerging consumer trends and health-focused product innovation during an interactive round table</li> <li>Explore a highly targeted, off-market opportunity in the dental wellness sector</li> </ul> <h4><br /> <span style="color:#f39c12"><strong>The agenda of the gathering:</strong></span></h4> <ul> <li>A round table with all investors, insights exchange</li> <li>An exploration of the exclusive opportunity offered by Remo Brush</li> <li>Following the live presentation from the founders, investors will engage in a collaborative feedback and co-development session</li> </ul> <p>&nbsp;</p> <h4>The session will conclude with a series of one-to-one investors&rsquo; meetings, allowing for deeper conversations with the founders and with like-minded leaders</h4> <p>&nbsp;</p> <h4><span style="color:#f39c12"><strong>About the opportunity:</strong></span><br /> RemoBrush is launching the world&rsquo;s first Miswak-infused toothbrush, with patents pending in the US, UK, Canada, Saudi Arabia, and the UAE. Created by a Harvard Dental Clinical Instructor,<strong> the product addresses two of the industry&rsquo;s biggest challenges: environmental waste and declining oral health.</strong> Combining a bamboo handle and bio-based bristles infused with Miswak, the brush naturally kills bacteria, whitens teeth, strengthens enamel, and reduces gum sensitivity. A magnetic attachment adds storage convenience and user appeal.</h4> <h4>&nbsp;</h4> <h4><span style="color:#f39c12"><strong>Breaking down the numbers:</strong></span><br /> <strong>RemoBrush is raising $500K to scale production</strong>, marketing, and distribution efforts. With<strong> margins reaching up to 92%,</strong> the business is designed for strong unit economics. The team is actively seeking investors as well as retail, hospitality, and distribution partners to support a rapid go-to-market strategy. The product is positioned for high-impact growth in both developed and emerging consumer health markets.</h4> <p>&nbsp;</p> <p><strong>The 223rd Co-Investing Atrium will be held via Zoom, running for 3 hours</strong></p> <address>(4&ndash;7 PM Dubai / 8&ndash;11 AM New York / 2&ndash;5 PM Zurich time).<br /> &nbsp;</address>